Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures
Open Access
- 28 September 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (10) , 3152-3162
Abstract
Objective: To investigate the role of oncostatin M (OSM) in cell adhesion, angiogenesis, and matrix degradation in rheumatoid arthritis (RA) synovial tissue and normal human cartilage.Methods: Human dermal microvascular endothelial cell (HDMEC) and RA synovial fibroblast (RASF) proliferation and intercellular adhesion molecule 1 (ICAM‐1) and vascular cell adhesion molecule 1 (VCAM‐1) expression were assessed by a bromodeoxyuridine proliferation assay and flow cytometry. HDMEC tubule formation and migration were assessed by Matrigel culture and migration assay. Production of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinases 1 (TIMP‐1) in RA synovial explants, and proteoglycan/glycosaminoglycan (GAG) release, vascular endothelial growth factor (VEGF), and angiopoietin 2 production from RASF/normal cartilage cocultures were assessed by enzyme‐linked immunosorbent assay and immunohistology.Results: HDMEC/RASF proliferation was induced by OSM and interleukin‐1β (IL‐1β), alone and in combination. OSM enhanced cell surface expression of ICAM‐1, but not VCAM‐1, on endothelial cells and RASFs. OSM increased endothelial cell tubule formation and migration. In RA synovial explants, OSM induced production of MMP‐1 and TIMP‐1. When OSM was combined with IL‐1β, however, the MMP‐1:TIMP‐1 ratio was significantly increased. OSM potentiated IL‐1β–induced MMP‐1 and MMP‐13 expression in normal human cartilage/RASF cocultures, resulting in a significant increase in the MMP:TIMP ratio. In OSM/IL‐1β– stimulated cocultures, cartilage sections demonstrated significant proteoglycan depletion that was paralleled by a significant increase in GAG release in supernatants. Finally, compared with either cytokine alone, the combination of OSM and IL‐1β significantly induced VEGF production in RASF/cartilage cocultures.Conclusion: These data suggest that OSM promotes angiogenesis and endothelial cell migration and potentiates the effects of IL‐1β in promoting extracellular matrix turnover and human cartilage degradation. Furthermore, the induction of VEGF in cocultures supports the hypothesis of a link between angiogenesis and cartilage degradation.Keywords
This publication has 47 references indexed in Scilit:
- Molecular therapeutic targets in rheumatoid arthritisExpert Reviews in Molecular Medicine, 2005
- Secretion of oncostatin M by neutrophils in rheumatoid arthritisArthritis & Rheumatism, 2004
- Cyclooxygenase 2–derived prostaglandin E2 production by corticotropin‐releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissueArthritis & Rheumatism, 2004
- Oncostatin M in combination with tumor necrosis factor α induces cartilage damage and matrix metalloproteinase expression in vitro and in vivoArthritis & Rheumatism, 2003
- Activated leucocytes express and secrete macrophage inflammatory protein-1 upon interaction with synovial fibroblasts of rheumatoid arthritis via a 2-integrin/ICAM-1 mechanismRheumatology, 2003
- Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdownArthritis & Rheumatism, 2001
- Oncostatin M stimulates monocyte chemoattractant protein‐1‐ and interleukin‐1‐induced matrix metalloproteinase‐1 production by human synovial fibroblasts in vitroArthritis & Rheumatism, 1997
- The alphas, betas, and kinases of cytokine receptor complexesCell, 1993
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988